<DOC>
	<DOCNO>NCT01263340</DOCNO>
	<brief_summary>The investigator describe characteristic , prevalence , incidence , severity co-morbidity management patient chronic obstructive pulmonary disease ( COPD ) UK . 100 practice sample amount total study population 10 000 patient . Information collect electronically , necessary , hand search patient record .</brief_summary>
	<brief_title>Characterisation People With COPD</brief_title>
	<detailed_description>Research question : 1 . What record prevalence COPD UK ? [ numerator : prevalence COPD define ANY current READ code COPD inclusion COPD register denominator : whole population ] - What proportion population document spirometry confirm diagnosis ? - What proportion document spirometry last year ? - What proportion ever document history asthma ? - What proportion currently document history asthma ? - What proportion currently smoke ? - What proportion smoker record receive smoke cessation advice ? - What proportion smoker prescription smoke cessation therapy ? - What proportion people COPD READ code exception reporting ? - What demographic feature ? ( height weight , BMI , age , smoke status , force expiratory flow 1st second ( FEV1_ , DOSE ) - What proportion people COPD READ code exception report spirometry ? - What demographic feature ? ( height , weight , body mass index ( BMI ) , age , smoke status , FEV1 , DOSE ) Sub analysis : description comparison prevalence • Age • geographical location participate practice • primary care training practice • number perform general practitioner ( GPs ) practice ( &lt; 3 v &gt; /= 3 ) 2 . What incidence COPD UK • number people new diagnosis COPD last year proportion whole population 3 . What distribution severity COPD ? • Description severity airflow obstruction FEV1 measurement : Mild ( FEV1 ≥ 80 % predict ) : Moderate ( FEV1 50 % 79 % predict ) Severe ( FEV1 30 % 49 % predict ) Very severe ( FEV1 ≤ 30 % predict ) • And DOSE Compare severity disease ( exacerbation rate ) accord DOSE `` high risk '' `` low risk '' compare stratification severity study population degree airflow limitation . • And COPD Assessment Test ( CAT ) Explore use CAT clinical practice availability spread data 4 . What exacerbation rate ? - In last year people diagnosis COPD &gt; 1 year - In last three year people diagnosis COPD &gt; 3years ( proportion population COPD ) . - What seasonal variation COPD exacerbation : proportion exacerbation occur month year ? - Do recurrent primary care manage exacerbation predict hospital admission ? What prior exacerbation rate patient admit hospital ? Population interest : hospital admission COPD : exacerbation rate ( time frame exacerbation ) prior hospital admission ? 4a . What proportion COPD population least one exacerbation ? Hospital attendance : Any documented visit secondary care ( primary care hour ) site overnight stay Hospital admission : Any documented visit secondary care site overnight stay principal diagnosis COPD chest infection pneumonia exacerbation asthma ICU admission : Any documented admission high dependency unit ( note , AN EXPLORATORY EXERCISE . Validity data primary care record questionable ) Death : Any death COPD document primary cause within 14 day onset exacerbation ( EXPLORATORY ) - Does DOSE predict undesirable outcome ( death , hospital admission , exacerbation rate ) ? - Does FEV1 predict undesirable outcome ( death , hospital admission , exacerbation rate ) ? - Does medical research council dyspnoea ( MRC ) score ( component DOSE ) predict undesirable outcome ? - Possible exploratory analysis : ADO index ( Age , Dyspnoea ( MRC score ) Obstruction ( FEV1 % pred ) ) predict undesirable outcome ? - Does number patient practice receive Tiotropium prescription predict hospital admission practice level ? 5 . Therapy : - What proportion patient ( without diagnosis asthma ) receive inhaled glucocorticosteroids unlicensed dos ( steroid ( fluticasone , budesonide , beclometasone , ciclesonide ) combination Seretide , Symbicort , Fostair ) EXCEPT Seretide Accuhaler 50/500 Symbicort ? - What proportion patient FEV1 &gt; 50 diagnosis asthma receive steroid preparation ? ( Note : Seretide Accuhaler 50/500 license use patient COPD ( pre-bronchodilator ) FEV1 &lt; 60 % predict therefore subject label use instance ) . The approach outline consensus purpose identify pragmatic approach data collection . - What proportion patient FEV &lt; 50 receive inhale steroid ? - What proportion patient 1 exacerbation last year receive inhale steroid ? - What proportion patient FEV1 &lt; 50 receive Seretide 50/500 Symbicort ? - What proportion patient `` triple therapy '' i.e . Seretide Symbicort PLUS Tiotropium , classify severity ( FEV1 ) - What refill rate prescription class ( SABA ) previous year ? - What proportion patient MRC dyspnoea score &gt; /= 3 ? - What proportion patient refer pulmonary rehabilitation ? - What proportion receive pulmonary rehabilitation ? - What proportion document evidence receive self management plan ? 6 . Co-morbidities : What proportion patient COPD READ code ever follow co-morbidities : - Cardiovascular disease - Cerebrovascular disease - Diabetes Mellitus - Cancer - Lung cancer - Depression - Osteoporosis What proportion patient least one comorbidity attend specialist chest service / clinic last year ? What exacerbation rate group v patient without comorbidity ? What hospital admission rate group v rest ? What proportion population record NEVER smoking ? What feature group ( age , sex , geography , exacerbation rate , medication , comorbidities 7 . Newly diagnose patient - What characteristic ( demographic : height weight , BMI , age , smoke status , FEV1 , DOSE ) newly diagnose patient ( first READ code COPD within last year ) ? - What proportion patient receive prescription Tiotropium within 1 month diagnosis ? - What proportion patient receive prescription inhale corticosteroid / longa act beta-agonist fix dose ( ICS / LABA ) combination within 1 month diagnosis ? - In patient FEV1 &lt; 50 % predict , proportion receive ) Tiotropium b ) ICS / LABA combination first - What proportion patient FEV1 &gt; 50 receive prescription ICS / LABA combination within 1 month diagnosis ? 8 . General Practice Research database ( GPRD ) - What proportion sample currently contribute GPRD database ? - Are difference feature two group : Age geographical location participate practice , primary care training practice , number perform GPs practice ( &lt; 3 v &gt; /= 3 ) , disease severity ( DOSE , FEV1 ) exacerbation rate 9 . What change practice level parameter last year ?</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>people read code diagnosis COPD</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>COPD</keyword>
	<keyword>observational study</keyword>
	<keyword>prevalence</keyword>
	<keyword>characterisation</keyword>
</DOC>